Financials
- Market Capitalization 4.59 B
- Employee 755
- Founded 2006
- CEO N/A
- Website www.veracyte.com
- Headquarter Delaware, United States
- FIGI BBG001J2M542
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1372 | LEGN Legend Biotech Corporation - American Depositary Shares | 25.75 USD | -4.91% | -8.72% | -27.51% | -19.48% | 4.76 B USD | ||
| 1374 | DFTX Definium Therapeutics, Inc. - Common Shares | 43.65 USD | -7.27% | -1.58% | +76.22% | +188.88% | 4.76 B USD | ||
| 1424 | EWTX Edgewise Therapeutics, Inc. - Common Stock | 41.27 USD | -9.12% | +1.90% | +16.45% | +170.98% | 4.44 B USD | ||
| 1425 | VKTX Viking Therapeutics, Inc. - Common Stock | 38.12 USD | -1.90% | -2.48% | +30.82% | +20.06% | 4.43 B USD |
Frequently asked questions about Veracyte, Inc. - Common Stock
What is the Veracyte, Inc. - Common Stock stock price today?
The current price of Veracyte, Inc. - Common Stock (VCYT) is 57.48. Over the past 24 hours, the stock has changed by +0.90%. Follow the VCYT chart for real-time price dynamics.
What is the stock ticker of Veracyte, Inc. - Common Stock?
Veracyte, Inc. - Common Stock trades under the ticker VCYT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Veracyte, Inc. - Common Stock stock going up?
VCYT has changed by -1.93% over the last week, +21.16% over the last month, and +55.77% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Veracyte, Inc. - Common Stock net income for the last quarter?
Veracyte, Inc. - Common Stock reported net income of 28.71 M for the last quarter. The previous quarter showed 41.15 M, which means net income changed by -30.24%.
How many employees does Veracyte, Inc. - Common Stock have?
As of the latest available data, Veracyte, Inc. - Common Stock has 755 employees. Workforce size can provide additional context about the company's scale and operations.
What is Veracyte, Inc. - Common Stock EBITDA?
Veracyte, Inc. - Common Stock EBITDA is 65.99 M, and its EBITDA margin is 47.45%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Veracyte, Inc. - Common Stock stock?
You can buy Veracyte, Inc. - Common Stock (VCYT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Veracyte, Inc. - Common Stock stock?
Investing in Veracyte, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VCYT chart and related analysis on metatrader.com as part of your research.